Imexpharm Corporation (HOSE:IMP)
47,500
-850 (-1.76%)
At close: Apr 28, 2026
10.72% (1Y)
| Market Cap | 7.32T |
| Revenue (ttm) | 2.39T |
| Net Income (ttm) | 311.12B |
| Shares Out | 154.01M |
| EPS (ttm) | 2,020.16 |
| PE Ratio | 23.51 |
| Forward PE | 19.92 |
| Dividend | 500.00 (1.03%) |
| Ex-Dividend Date | Jun 9, 2025 |
| Volume | 18,623 |
| Average Volume | 44,465 |
| Open | 47,000 |
| Previous Close | 48,350 |
| Day's Range | 47,000 - 47,950 |
| 52-Week Range | 42,600 - 57,000 |
| Beta | 0.61 |
| RSI | 16.63 |
| Earnings Date | Jul 17, 2026 |